These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15708437

  • 1. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
    Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E.
    Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
    [Abstract] [Full Text] [Related]

  • 2. Fyn, a potential target for Alzheimer's disease.
    Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, MacDonald JF.
    J Alzheimers Dis; 2011 May; 27(2):243-52. PubMed ID: 21799250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT, Trojanowski JQ, Lee VM.
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amyloid-beta, tau, and dementia.
    Takashima A.
    J Alzheimers Dis; 2009 Feb; 17(4):729-36. PubMed ID: 19542626
    [Abstract] [Full Text] [Related]

  • 10. Pick bodies in a family with presenilin-1 Alzheimer's disease.
    Halliday GM, Song YJ, Lepar G, Brooks WS, Kwok JB, Kersaitis C, Gregory G, Shepherd CE, Rahimi F, Schofield PR, Kril JJ.
    Ann Neurol; 2005 Jan; 57(1):139-43. PubMed ID: 15622541
    [Abstract] [Full Text] [Related]

  • 11. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
    Anthony IC, Norrby KE, Dingwall T, Carnie FW, Millar T, Arango JC, Robertson R, Bell JE.
    Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
    [Abstract] [Full Text] [Related]

  • 12. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
    Masliah E, Mallory M, Alford M, Hansen LA, Saitoh T.
    Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
    [Abstract] [Full Text] [Related]

  • 13. [Significance of tau in the development of Alzheimer's disease].
    Takashima A.
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [Abstract] [Full Text] [Related]

  • 14. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease.
    Iwai A, Masliah E, Sundsmo MP, DeTeresa R, Mallory M, Salmon DP, Saitoh T.
    Brain Res; 1996 May 13; 720(1-2):230-4. PubMed ID: 8782917
    [Abstract] [Full Text] [Related]

  • 15. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.
    J Alzheimers Dis; 2010 May 13; 22(4):1363-73. PubMed ID: 20930272
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E.
    Histol Histopathol; 1995 Apr 13; 10(2):509-19. PubMed ID: 7599445
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM.
    Am J Pathol; 1993 Aug 13; 143(2):565-78. PubMed ID: 8342603
    [Abstract] [Full Text] [Related]

  • 18. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C, Colle MA, Delatour B, Hauw JJ.
    Rev Neurol (Paris); 1999 Aug 13; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [Abstract] [Full Text] [Related]

  • 19. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A, Shepherd CE, Sokolova A, Carroll VL, King AE, Halliday GM, Dickson TC, Vickers JC.
    Acta Neuropathol; 2009 Jan 13; 117(1):19-29. PubMed ID: 19015863
    [Abstract] [Full Text] [Related]

  • 20. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.
    Pearson AG, Byrne UT, MacGibbon GA, Faull RL, Dragunow M.
    Neurosci Lett; 2006 May 08; 398(3):246-50. PubMed ID: 16481106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.